The device could upend treatment for the 33 million to 45 million Americans with severe allergies to food and other triggers.

FDA officials say this is the first epinephrine product for anaphylaxis that is not administered with a needle.

The maker of a homeopathic nasal spray with a history of contamination is refusing to recall its product after the Food and ...

The FDA has approved a nasal spray, called neffy, to treat serious allergic reactions in adults and children who weigh at ...

SoundHealth launched a new feature in its AI-powered health care app that will give users personalized allergy forecasts to ...

The FDA announced earlier today that ilunocitinib tablets (Zenrelia; Elanco) has received its approval. The latest drug from ...

The FDA recently approved the first needle-free epinephrine product (neffy), an alternative to injectable epinephrine (EpiPen ...

A nasal spray developed ... Research shows the spray, recently approved in the EU and US, is just as effective at stopping ...

ARS Pharmaceuticals' neffy, a needle-free nasal spray for allergies, receives FDA approval, driving stock price up 120%. Read ...

We came across a bullish thesis on ARS Pharmaceuticals (SPRY) on Value Degen’s Substack by Unemployed Value Degen. In this ...

The FDA has approved AstraZeneca's Fasenra for eosinophilic granulomatosis with polyangiitis based on Phase 3 MANDARA trial ...